In vivo imaging and tumor therapy with the sodium iodide symporter.
about
Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancerThe sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapiesMeasles to the Rescue: A Review of Oncolytic Measles VirusThe use of the NIS reporter gene for optimizing oncolytic virotherapyMutant sodium channel for tumor therapy.Directed evolution generates a novel oncolytic virus for the treatment of colon cancerNoninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter.In vitro radionuclide therapy and in vivo scintigraphic imaging of alpha-fetoprotein-producing hepatocellular carcinoma by targeted sodium iodide symporter gene expression.Current issues and future directions of oncolytic adenoviruses.Sodium iodide symporter (NIS)-mediated radiovirotherapy of hepatocellular cancer using a conditionally replicating adenovirus.Engineered measles virus Edmonston strain used as a novel oncolytic viral system against human hepatoblastoma.Codon-optimized human sodium iodide symporter (opt-hNIS) as a sensitive reporter and efficient therapeutic gene.Image-guided, tumor stroma-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated NIS gene deliverySodium iodide symporter (NIS)-mediated radionuclide ((131)I, (188)Re) therapy of liver cancer after transcriptionally targeted intratumoral in vivo NIS gene deliveryImage-guided tumor-selective radioiodine therapy of liver cancer after systemic nonviral delivery of the sodium iodide symporter gene.Tissue-specific promoters for cancer gene therapy.Attenuated oncolytic measles virus strains as cancer therapeuticsRadioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene.Stromal targeting of sodium iodide symporter using mesenchymal stem cells allows enhanced imaging and therapy of hepatocellular carcinoma.Oncolytic measles virus strains as novel anticancer agents.Quantitative molecular imaging of viral therapy for pancreatic cancer using an engineered measles virus expressing the sodium-iodide symporter reporter gene.Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: an overview.The biology of the sodium iodide symporter and its potential for targeted gene delivery.Genetics and phenomics of hypothyroidism and goiter due to NIS mutations.Oncolytic virotherapyAntiglioma oncolytic virotherapy: unattainable goal or a success story in the making?Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects.Oncolytic Recombinant Vesicular Stomatitis Virus (VSV) Is Nonpathogenic and Nontransmissible in Pigs, a Natural Host of VSV.Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer.Gamma camera and optical imaging with a fusion reporter gene using human sodium/iodide symporter and monomeric red fluorescent protein in mouse model.Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.Oncolytic viruses: the power of directed evolution.EGFR-targeted nonviral NIS gene transfer for bioimaging and therapy of disseminated colon cancer metastases.Systemic tumor-targeted sodium iodide symporter (NIS) gene therapy of hepatocellular carcinoma mediated by B6 peptide polyplexes.Estimation of Oncolytic Virus Populations within Tumors
P2860
Q24611278-166DCD4C-3930-41AF-A9C2-6EF53ECA5AD2Q27023157-845408E3-1282-4B65-B102-82F2129B62F5Q28072097-4C62176A-B996-46E7-8BF6-348FA00B2068Q28083534-B27FD811-4F37-4616-836A-A3C7906E5C96Q30481753-0BD7771D-AFD2-4214-8104-A8AF8CA3415FQ33344440-BABB2EF3-2FD5-4727-B06E-B9DE9A425974Q33605148-7761AAFD-36C0-46B4-B866-6D0104C437D2Q33670033-4E985548-9302-4521-8F08-804BBB02EBDAQ33730705-D113825F-5D05-41C9-B7FB-5C92AF4937B3Q34303955-D66AB400-D9AF-47C8-B88D-39799C3C2D69Q34421151-3ED93D86-352C-48F4-8F92-2392F7B83FE3Q34698684-9FC26234-DE9B-48E5-A4B8-14AF418CBACBQ35238289-51EBE813-E002-48F4-91DA-77BD2B648D04Q35575677-BA4A3B75-3C79-4CEF-9306-0F72022E3033Q35612571-F0E0F62E-BABE-4221-8858-59ED997BB067Q35779378-1C7F5D02-E8D0-4DA6-938D-09666292E45FQ35818876-DBFA7808-F4E0-48AC-8D55-642483FF853CQ36007610-4C12729A-EE84-4D75-9DD8-C11B12606A3AQ36720696-79D6D710-A896-4CA2-A1D7-F51162AEBCDDQ37261017-6A8363B5-B7D5-42ED-B9FC-002B82E6B4F3Q37262334-2F9D30DA-C9F4-413A-87A9-EF183DF61387Q37280354-FEA92CAE-6485-4FDB-BD62-6753AFB672CDQ37564872-73E09B8F-5764-49B1-9FBD-DA233924F8BBQ37691930-55419F3F-509D-460B-BCBA-D07D0A9DB4D7Q38025263-E1E228F3-71FE-4DCE-B6F4-0C9E1070F64BQ38218674-512CB2BC-E620-4D58-8A3E-DA214EAF669DQ38754467-F7097151-EB20-4388-AC69-D710526E1C57Q38780400-B14B22FE-7B7B-4046-A09C-6D2A1A48E6B6Q38799217-DE209067-6CD9-4A12-A70C-12A2EB171898Q39460057-11375BEC-8691-4908-9277-2C57E8BF6977Q40054917-89040D50-D1F9-4905-B9A2-E3820A574DC0Q40498934-537E9E36-A002-45DB-A351-039E9B5FADAEQ40630931-840C946C-12E2-4CA1-B98D-A2B87DDCDD74Q45326571-0CA45A90-32CE-4753-B8AE-BAAD304206DAQ45866837-41A72F78-21CE-448B-8734-68F1C6AB1CBFQ57462027-9944D8E6-FBF5-42F6-84C2-FE99A858C608
P2860
In vivo imaging and tumor therapy with the sodium iodide symporter.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
In vivo imaging and tumor therapy with the sodium iodide symporter.
@ast
In vivo imaging and tumor therapy with the sodium iodide symporter.
@en
type
label
In vivo imaging and tumor therapy with the sodium iodide symporter.
@ast
In vivo imaging and tumor therapy with the sodium iodide symporter.
@en
prefLabel
In vivo imaging and tumor therapy with the sodium iodide symporter.
@ast
In vivo imaging and tumor therapy with the sodium iodide symporter.
@en
P356
P1476
In vivo imaging and tumor therapy with the sodium iodide symporter.
@en
P2093
John C Morris
P304
P356
10.1002/JCB.10714
P577
2003-12-01T00:00:00Z